Sep 15, 2020 | All News, Awareness and Information
The Pheo Para Alliance launched the inaugural campaign to raise awareness for pheochromocytoma (pheo) and paraganglioma (para), rare neuroendocrine tumors, from August 23 – 29. The objectives of this week-long campaign were to inspire & empower pheo para...
Sep 1, 2020 | All News, Awareness and Information, Uncategorized
Between July 1st and September 7th, the Canadian neuroendocrine cancer community is working together in an effort to raise $100,000 in the 2020 Neuroendocrine cancer research fundraising campaign, HOOFING IT Across Canada for Neuroendocrine Cancer Research! After 45...
Aug 30, 2020 | All News, Awareness and Information
During the inaugural, international Phaeo Para Awareness Week (24-30 August), AMEND were delighted to launch a brand new group identity for patients and families in the UK affected by phaeochromocytoma and paraganglioma tumors and syndromes. Phaeo Para Support UK is...
Aug 28, 2020 | All News, INCA
INCA is pleased to share that the ASCO Quality Care Symposium Program Committee accepted INCA’s abstract “Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients (SCAN) – Global Disparities in Quality Healthcare for NETs”...
Aug 27, 2020 | All News, Research and Clinical Trials
INCA Research Chair and NeuroEndocrine Cancer Australia CEO, Simone Leyden, was honoured to be an author on a recently published consensus guideline in the esteemed Journal of Thoracic Oncology along with colleagues from CommNETs (Commonwealth Neuroendocrine Tumour...
Aug 26, 2020 | All News, Awareness and Information
World NEN Lives 2020 congress will be held first time this September 23-24 virtually via ZOOM. This congress is designed to showcase treatment options and ways to live better with and around NENs. The speakers include some of the top NEN world specialists as well as...
